Glaxo

GSK is a leading global biopharmaceutical company headquartered in London, dedicated to the discovery, development, and manufacturing of innovative medicines and vaccines. The company focuses on four core therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. GSK's portfolio includes blockbuster products such as Shingrix for shingles prevention, Trelegy for respiratory health, and a dominant position in the HIV market through its majority-owned subsidiary ViiV Healthcare. Following the 2022 demerger of its consumer health division, Haleon, GSK has transitioned into a pure-play biopharma entity with a heightened emphasis on R&D productivity and specialty medicines. The company leverages advanced technologies, including functional genomics and artificial intelligence, to accelerate its pipeline of next-generation therapies.